294 related articles for article (PubMed ID: 1838532)
1. [Immunologic suppression of experimental autoimmune uveitis].
Thurau SR; Caspi RR; Chan CC; Weiner HL; Nussenblatt RB
Fortschr Ophthalmol; 1991; 88(4):404-7. PubMed ID: 1838532
[TBL] [Abstract][Full Text] [Related]
2. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
Nussenblatt RB; Caspi RR; Mahdi R; Chan CC; Roberge F; Lider O; Weiner HL
J Immunol; 1990 Mar; 144(5):1689-95. PubMed ID: 2137841
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
Singh VK; Anand R; Sharma K; Agarwal SS
Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
[TBL] [Abstract][Full Text] [Related]
7. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization].
Misiuk-Hojło M; Ruiz-Moreno J; Thillaye B; de Kozak Y
Klin Oczna; 1993; 95(3-4):101-4. PubMed ID: 8377430
[TBL] [Abstract][Full Text] [Related]
8. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant Escherichia coli expressing retinal S-antigen-induced experimental autoimmune uveitis (EAU) in Lewis rats.
Eto K; Suzuki S; Singh VK; Shinohara T
Cell Immunol; 1993 Mar; 147(1):203-14. PubMed ID: 8462112
[TBL] [Abstract][Full Text] [Related]
10. Ocular injection of retinal S antigen: suppression of autoimmune uveitis.
Mizuno K; Clark AF; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):772-4. PubMed ID: 2784789
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of autoimmune uveitis by anti-CD4 antibody.
Atalla L; Linker-Israeli M; Steinman L; Rao NA
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1264-70. PubMed ID: 1973156
[TBL] [Abstract][Full Text] [Related]
12. Modulation of experimental autoimmune uveoretinitis by adoptive transfer of cells from rats immunized with anti-S-antigen monoclonal antibody.
de Kozak Y; Mirshahi M; Boucheix C; Faure JP
Reg Immunol; 1989; 2(5):311-20. PubMed ID: 2485681
[TBL] [Abstract][Full Text] [Related]
13. [The suppression of the experimental autoimmune uveoretinitis with retinal S antigens by intranasal tolerance induction].
Zheng YZ; Yuan LL; Lin JY; Li HQ
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1118-22. PubMed ID: 17415971
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide.
Singh VK; Kalra HK; Yamaki K; Shinohara T
Cell Immunol; 1992 Jan; 139(1):81-90. PubMed ID: 1728971
[TBL] [Abstract][Full Text] [Related]
15. Identification of a uveitogenic cyanogen bromide peptide of bovine retinal S-antigen and preparation of a uveitogenic, peptide-specific T cell line.
Gregerson DS; Obritsch WF; Fling SP
Eur J Immunol; 1987 Mar; 17(3):405-11. PubMed ID: 3494613
[TBL] [Abstract][Full Text] [Related]
16. Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20mer peptide.
Thurau SR; Chan CC; Suh E; Nussenblatt RB
J Autoimmun; 1991 Jun; 4(3):507-16. PubMed ID: 1910426
[TBL] [Abstract][Full Text] [Related]
17. Effects of bucillamine, a new anti-rheumatic drug, on the experimental autoimmune uveitis in rats.
Sawa K; Mochizuki M
Exp Eye Res; 1994 Apr; 58(4):431-8. PubMed ID: 7925680
[TBL] [Abstract][Full Text] [Related]
18. Oligopeptides of three to five residues derived from uveitopathogenic sites of retinal S-antigen induce experimental autoimmune uveitis (EAU) in Lewis rats.
Sunil S; Eto K; Singh VK; Shinohara T
Cell Immunol; 1993 Apr; 148(1):198-207. PubMed ID: 8495487
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes.
Merryman CF; Donoso LA; Zhang XM; Heber-Katz E; Gregerson DS
J Immunol; 1991 Jan; 146(1):75-80. PubMed ID: 1701801
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of experimental autoimmune uveitis using a rat anti retinal S-antigen specific monoclonal antibody: evidence for a species difference.
Dua HS; Liversidge J; Forrester JV
Eye (Lond); 1989; 3 ( Pt 1)():69-78. PubMed ID: 2591601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
